Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint (Q3391873)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint |
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint |
scientific article |
Statements
Intermediate Monitoring, Sample Size Reassessment, and Multi-Treatment Optimal Response-Adaptive Designs for Phase III Clinical Trials with More Than One Constraint (English)
0 references
13 August 2009
0 references
constraints
0 references
ethical allocation
0 references
group sequential designs
0 references
minimization
0 references
0.89815164
0 references
0.88966113
0 references
0.88359797
0 references
0.8700606
0 references
0.8680451
0 references
0.8582105
0 references
0.85772157
0 references
0.85737085
0 references
